Astrazeneca Invests $2.1 Million in Support of Cancer Research in BC

Date Posted: 
2010-03-04

Investment recognizes world class oncology research and development expertise at BC Cancer Agency and Vancouver Prostate Centre.

MISSISSAUGA, ONTARIO – AstraZeneca Canada is pleased to announce a $500,000 investment to support oncology research and development at the BC Cancer Agency (BCCA). This adds to the $700,000 Vancouver Prostate Centre investment made in January, and represents a significant collaboration with leading British Columbia breast and prostate cancer researchers.

"We are very proud to support these research projects and the world renowned physicians who undertake them," said Mark Jones, President of AstraZeneca Canada. "We are committed to working collaboratively with organizations such as the BCCA, to improve the lives of cancer patients. We believe these initiatives will help address real-life needs."

The first of three key research projects looks at genomic characterizations of prostate and genitourinary cancers. This work will be conducted in collaboration with the Vancouver Prostate Centre at Vancouver Hospital. The second supports new ways of encouraging adherence to cancer treatments, as well as looking for particular biomarkers in breast cancer patients receiving hormonal therapies. And the third aims to find better measures of quality of life for clinical trial cancer patients.

"Understanding the genetic changes in cancers in relation to their response to treatment is fundamental in developing new individualized therapies," says Dr. Kim Chi, Chair of the Genitourinary Tumour Group and medical oncologist at the BC Cancer Agency, and researcher with the Vancouver Prostate Centre at Vancouver Hospital. "With this new funding from AstraZeneca we will be able to work on a number of innovative research projects which will hopefully one day lead to the development of more targeted therapies."

In addition to the BCCA grant, the Vancouver Prostate Centre will receive funding over a two year period, to investigate the effectiveness of early stage therapies in treatment resistant prostate cancer, an area of high unmet need. The research will try to better understand novel ways of blocking a specific protein, called the androgen receptor. This receptor plays a key role in the tumour developing resistance to current treatments.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

It's A Snow Day

It's A Snow Day: Friday March 8

It's A Snow Day at Mt. Seymour, a fundraiser for Prostate Cancer Foundation BC, is being held on Friday March 8, 2019. Visit the event website for more details, and to register and/or sponsor a participant, or donate directly to Prostate Cancer Foundation BC.

10th Anniversary Ride to Live

West Coast Motorcycle Ride To Live: May 26th

The 10th Anniversary West Coast Motorcycle Ride to Live is taking place in Vancouver and the Fraser Valley on May 26 (Victoria date to be finalized), with details on the event and how to register on the event website.  This fundraiser for Prostate Cancer Foundation BC includes a 50/50 raffle open to all BC residents over age 19.

Employment

Work at the Vancouver Prostate Centre

Tuesday, November 27, 2018

An innovative new study advances personalized medicine for prostate cancer patients

Drs Chi and Wyatt
Tuesday, October 23, 2018

Three researchers receive Prostate Cancer Canada & Movember Foundation grants for biomarker development